Mallinckrodt Inc. Begins Trading on New York Stock Exchange
7/1/2013 8:47:07 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DUBLIN--(BUSINESS WIRE)--Mallinckrodt plc (NYSE: MNK) begins “regular-way” trading today on the New York Stock Exchange as an independent, global specialty pharmaceuticals company under the symbol MNK. Mallinckrodt completed its previously announced separation from Covidien plc (NYSE: COV) in a spin-off to shareholders on Friday, June 28.
Help employers find you! Check out all the jobs and post your resume.